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Hospitals’ star ratings and clinical outcomes:
ecological study
Kathy Rowan, David Harrison, Anthony Brady, Nick Black
The English Department of Health is developing
global measures of the performance of all NHS bodies,
including 166 acute hospital trusts. Since 2000-1, the
trusts get zero, one, two, or three stars to indicate per-
formance.1 This rating may not reflect the effectiveness
of clinical care measured in patient outcomes because
of the lack of accurate routine data.2 One exception is
in adult critical care3; we checked whether a hospital’s
rating provided an indication of its clinical outcomes.
Methods and results
We compared the 2001-2 rating of 102 acute hospital
trusts for which we had validated data for that year. We
calculated each patient’s predicted risk of death before
discharge from hospital4 and compared it with actual
mortality for all admissions in 2001-2 for each unit.
We compared rating with crude mortality at the
patient level rather than aggregated by hospital; our
sample of hospitals with all hospitals; and university
with non-university hospitals using 2 tests for trend.
We compared rating with size of intensive care unit and
mean age of patients, using Spearman’s . We
calculated confidence intervals for mortality adjusted
for risk, using logistic regression of mortality on rating
and predicted log odds of mortality. We tested rating
and adjusted mortality using the likelihood ratio test.
The distribution of ratings for the 102 acute hospi-
tal trusts was similar to that for all 166 trusts (2 = 1.7;
P = 0.19). Rating was associated with teaching status
(university hospitals had more stars than non-
university hospitals—52% v 29% had three, 38% v 45%
had two, 5% v 19% had one, 5% v 7% had zero; 2 = 3.9;
P = 0.05) but not size of its critical care unit
(Spearman’s = 0.09; P = 0.34).
Rating and crude mortality for critical care admis-
sions were significantly associated (2 = 4.1; df = 1;
P = 0.04) (figure): mortality in trusts with three stars
was about 4% lower than in trusts with zero stars. How-
ever, case mix of critical care admissions also differed
considerably. Rating was inversely associated with the
mean age of critical care admissions (= − 0.19;
P = 0.04). The association between rating and hospital
mortality was no longer significant when case mix
differences were taken into account (P = 0.4) (figure).
Comment
For adult critical care, star ratings do not reflect the
quality of clinical care provided by hospitals. Patients
do just as well in a trust with no stars as they do in one
with three stars. Crude mortality data are misleading
because they ignore the fact that higher rated trusts
tend to be teaching institutions with patients who are
less severely ill on admission to critical care units.
We did not expect to find an association between
the rating of the whole trust and the effectiveness of
critical care. Firstly, hospitals are complex organisa-
tions containing many services; performance across a
hospital will not be uniform—a poorly rated hospital
may contain some excellent services and vice versa.
Secondly, ratings are determined by a small number of
process measures; outcome measures play only a small
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role and are based on scant poor quality data, which do
not adequately account for case mix.
The study’s principal limitation is its confinement to
one small, though important, group of patients and
services. Our findings may be atypical, and trusts’ ratings
may reflect outcomes elsewhere in hospital care.
If these findings reflect other areas of hospital care,
the government is not yet fulfilling its “commitment to
provide patients and the general public with compre-
hensive, easily understandable information on the
performance of their local health services.”1 Outcome
ought to be a principal concern alongside process indi-
cators, such as waiting times and cleanliness; to fulfil its
aim, the government needs to use specialised clinical
databases (accessible through www.docdat.org).5
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Pertussis vaccination in infancy and asthma or allergy in
later childhood: birth cohort study
Anirban Maitra, Andrea Sherriff, Mansel Griffiths, John Henderson, Avon Longitudinal Study of
Parents and Children Study Team
Some studies have shown a link between vaccination of
infants with whole cell inactivated pertussis vaccine and
the later development of asthma and atopy.1 2 A
randomised controlled trial disagreed with these
findings, but follow up was done until only 30 months of
age.3 Our previous report of the lack of an association
between pertussis vaccination and wheezing disorders
was based on outcomes in early childhood.4 In this study
we have examined the association between pertussis
vaccination in infancy and asthma or atopy by age 7.5
years in a large, population based birth cohort.
Participants, methods, and results
Participants were the 13 971 children who survived to 1
year in the Avon longitudinal study of parents and chil-
dren. The study method has been described previously,5
and details can be found on the study website
(www.alspac.bris.ac.uk). We obtained the vaccination sta-
tus for each child from the child health surveillance
database.We categorised children with regard to pertus-
sis as fully vaccinated (completed a primary course of
diphtheria, tetanus, and pertussis vaccination), partially
vaccinated (completed a primary course of diphtheria
and tetanus but did not receive pertussis vaccine) or
non-vaccinated (no vaccinations). We excluded other
combinations from analysis. We obtained three wheez-
ing outcomes based on parental self report question-
naires (asthma at 69-81 months, wheeze with whistling
on the chest at 69-81 months, and asthma diagnosed by
a doctor at 91 months) and one atopy outcome based on
skin prick tests at age 7 years.We defined atopy as one or
more positive reactions (wheal ≥ 2 mm) to a panel of
three common allergens.We selected several variables as
potential confounders of the relation between exposure
and outcome, which were, however, not considered to be
in the causal pathway. These were, from mother’s
questionnaire data: maternal education, maternal smok-
ing during pregnancy, maternal history of asthma or
eczema, maternal financial difficulties, damp housing,
overcrowding, child’s ethnicity, number of siblings,
contact with cats in the home, duration of breast feeding,
and passive exposure to tobacco smoke; and, from
medical records: birth weight, sex, gestational age, and
maternal age at delivery. We used Pearson’s 2 (or
Fisher’s exact test if the predicted number of subjects in
any category was less than five) for our data analysis of
univariable associations between vaccination status and
possible confounders and principal outcomes. We used
multivariable logistic regression models to evaluate
associations between immunisation status and asthma
and allergy outcomes while controlling for potential
confounders.
Vaccination history was available for 13 810 chil-
dren, of whom 13 109 (94.9%) were fully vaccinated, 446
did not have pertussis vaccination (340 non-vaccinated;
106 partially vaccinated), and 255 had some other com-
bination. The table shows numbers of subjects with out-
come data for each of the principal outcomes. The
cumulative prevalence of asthma diagnosed by doctors
was 20.3% (n = 1597) at 91 months. The prevalence of
reported asthma at 69-81 months was 12.4% (n = 1024),
reported wheeze with whistling at 69-81 months 9.8%
(n = 798) and atopy at 7 years 20.5% (n = 1324). The
table shows the adjusted and unadjusted odds ratios and
95% confidence intervals from logistic regressions for
each of the principal outcomes. Although unadjusted
analyses showed significant associations (asthma at
A supplemental table is on bmj.com
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